Compare RVTY & JEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVTY | JEF |
|---|---|---|
| Founded | 1937 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 11.1B |
| IPO Year | 1994 | 2010 |
| Metric | RVTY | JEF |
|---|---|---|
| Price | $92.22 | $43.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 5 |
| Target Price | ★ $113.00 | $76.00 |
| AVG Volume (30 Days) | 1.3M | ★ 3.2M |
| Earning Date | 04-27-2026 | 04-13-2026 |
| Dividend Yield | 0.29% | ★ 3.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.07 | ★ 2.83 |
| Revenue | $3,311,822,000.00 | ★ $10,823,677,000.00 |
| Revenue This Year | $6.34 | $15.43 |
| Revenue Next Year | $5.10 | $8.74 |
| P/E Ratio | $46.38 | ★ $16.05 |
| Revenue Growth | N/A | ★ 2.93 |
| 52 Week Low | $81.36 | $39.28 |
| 52 Week High | $120.39 | $71.04 |
| Indicator | RVTY | JEF |
|---|---|---|
| Relative Strength Index (RSI) | 34.18 | 24.39 |
| Support Level | $88.56 | N/A |
| Resistance Level | $95.99 | $59.10 |
| Average True Range (ATR) | 3.21 | 2.85 |
| MACD | -0.46 | -0.98 |
| Stochastic Oscillator | 0.47 | 0.78 |
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Jefferies Financial Group is a full-service investment banking and capital markets firm that was founded in 1962. After nearly 30 years of focusing on institutional trading services, it entered the investment banking industry in the early 1990s, which ultimately grew into the core business. In 2013, Jefferies merged with Leucadia, a manufacturing-focused holding company. Since merging, Jefferies became the bedrock of the business as the bulk of the legacy portfolio was sold off and the parent company was renamed to match the subsidiary. Within the investment banking landscape, Jefferies predominately serves the North American middle market and has captured considerable market share over the past decade.